Interwell Health Achieves Notable Accreditation in Kidney Care for Three Years
Interwell Health Achieves Prestigious NCQA Accreditation
Interwell Health, a leader in value-based kidney care, has been awarded a three-year accreditation by the National Committee for Quality Assurance (NCQA) for its comprehensive care program, Interwell 360. This recognition underscores the organization’s dedication to delivering exceptional, patient-centric services to individuals confronting chronic kidney disease (CKD).
Commitment to Quality Care
At the heart of Interwell’s philosophy is a focus on enhancing the quality of care provided to patients. As stated by CEO Robert Sepucha, each initiative and strategy implemented is designed to make a tangible positive impact on the lives of those affected by kidney issues. The organization prioritizes early interventions and provides a holistic support network to ensure safety, excellence, and improved outcomes for patients.
Interwell collaborates with both regional and national payers, establishing partnerships with physicians to drive advancements in the health of their CKD patients while effectively managing costs. The company employs an interdisciplinary team comprising nurses, dietitians, social workers, and care coordinators who engage with patients between medical appointments to combat the progression of the disease.
Advanced Predictive Models
Utilizing predictive analytics, Interwell identifies patients at the highest risk for disease progression and potential hospitalizations. In addition, a specially trained care team is rapidly mobilized to provide outreach immediately following patient discharge from hospitals, significantly reducing the chances of readmissions.
Dr. George Hart, the Chief Medical Officer at Interwell Health, emphasized the importance of this accreditation, stating, "It reflects our team's unwavering commitment to the health and well-being of kidney disease patients, ensuring high-quality care throughout all stages of their healthcare journey."
NCQA’s Role in Healthcare Excellence
The NCQA is an independent, nonprofit entity focused on assessing and promoting the quality of various healthcare plans and organizations. It grants the status of Accredited–3 years to entities that demonstrate robust performance in accordance with its standards. The standards for Population Health Program (PHP) Accreditation are created through collaboration with numerous stakeholders, including health plans and industry leaders.
In the words of Margaret E. O'Kane, president of NCQA, the Population Health Management program reflects a deeper commitment to person-centered healthcare management. It not only adds value to existing efforts for quality improvement but also showcases the organization’s highest commitment to enhancing quality of care to meet patient needs.
Previous Accreditations and Future Goals
Back in January 2022, Interwell’s predecessor, Fresenius Health Partners, secured NCQA’s PHP Accreditation for its KidneyCare365 initiative. Following a merger, this achievement marks Interwell’s inaugural NCQA review and audit post-merger.
Interwell Health's ongoing mission is to reinvent the landscape of kidney healthcare, enabling patients to lead healthier, fulfilling lives. Their innovative approach combines total patient care with provider support, managing CKD patients from stage 3 through to end-stage kidney failure.
The company is dedicated to setting industry standards and demonstrates this through its collaborations with over 2,000 nephrologists nationwide, employing advanced machine learning algorithms to personalize patient care effectively.
To find out more about Interwell Health and its transformative strategies in kidney care, visit their official website.
Conclusion
Achieving the NCQA Population Health Program Accreditation is a significant milestone for Interwell Health, reaffirming its status as a frontrunner in value-based kidney care. The organization continues to strive for excellence by prioritizing patient needs and driving improvements in healthcare delivery for chronic kidney disease patients.